MoonLake Immunotherapeutics - Class A Ordinary Shares financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 10/08/2026 | Mar 2026Filed 11/05/2026 | Sep 2025Filed 05/11/2025 | Jun 2025Filed 10/08/2026 | Mar 2025Filed 11/05/2026 | Sep 2024Filed 05/11/2025 | Jun 2024Filed 05/08/2025 | Mar 2024Filed 12/05/2025 |
|---|---|---|---|---|---|---|---|---|
| −$62 | −$70 | −$70 | −$55 | −$40 | −$35 | −$24 | −$14 | |
| −$0.84 | −$0.98 | −$1.10 | −$0.87 | −$0.63 | −$0.56 | −$0.39 | −$0.22 | |
| 74 | 71 | 63 | 63 | 63 | 63 | 63 | 63 |
Trend